Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
Progress in Retinal and Eye Research
|
March 29, 2021
Mesenchymal stromal cells for the treatment of ocular autoimmune diseases
Joo Youn Oh, Ryang Hwa Lee
Stem Cells (Dayton, Ohio)
|
March 9, 2023
Revisiting the Mesenchymal "Stem vs. Stromal" Cell Dichotomy and Its Implications for Development of Improved Potency Metrics
Donald G Phinney, Ryang Hwa Lee, Siddaraju V Boregowda
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 26, 2017
Data against a Common Assumption: Xenogeneic Mouse Models Can Be Used to Assay Suppression of Immunity by Human MSCs
Darwin J Prockop, Joo Youn Oh, Ryang Hwa Lee
Stem Cell Research & Therapy
|
September 2, 2016
Mechanisms of mesenchymal stem/stromal cell function
Jeffrey L Spees, Ryang Hwa Lee, Carl A Gregory
Journal of Cellular Biochemistry
|
July 13, 2011
Therapeutic factors secreted by mesenchymal stromal cells and tissue repair
Ryang Hwa Lee, Joo Youn Oh, Hosoon Choi, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
July 30, 2016
Stanniocalcin-1 attenuates ischemic cardiac injury and response of differentiating monocytes/macrophages to inflammatory stimuli
Arezoo Mohammadipoor, Ryang Hwa Lee, Darwin J Prockop, et al.
Cytotherapy
|
August 1, 2015
Pre-activated human mesenchymal stromal cells in combination with doxorubicin synergistically enhance tumor-suppressive activity in mice
Nara Yoon, Min Sung Park, Grantham C Peltier, et al.
The Ocular Surface
|
February 19, 2021
Mesenchymal stromal cells for corneal transplantation: Literature review and suggestions for successful clinical trials
Joo Youn Oh, Eunjae Kim, Young In Yun, et al.
Cell Stem Cell
|
November 13, 2012
Preactivation of human MSCs with TNF-α enhances tumor-suppressive activity
Ryang Hwa Lee, Nara Yoon, John C Reneau, et al.
Diabetes
|
January 26, 2013
TSG-6 produced by hMSCs delays the onset of autoimmune diabetes by suppressing Th1 development and enhancing tolerogenicity
Daniel J Kota, Lindsey L Wiggins, Nara Yoon, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
Progress in Retinal and Eye Research
|
March 29, 2021
Mesenchymal stromal cells for the treatment of ocular autoimmune diseases
Joo Youn Oh, Ryang Hwa Lee
Stem Cells (Dayton, Ohio)
|
March 9, 2023
Revisiting the Mesenchymal "Stem vs. Stromal" Cell Dichotomy and Its Implications for Development of Improved Potency Metrics
Donald G Phinney, Ryang Hwa Lee, Siddaraju V Boregowda
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 26, 2017
Data against a Common Assumption: Xenogeneic Mouse Models Can Be Used to Assay Suppression of Immunity by Human MSCs
Darwin J Prockop, Joo Youn Oh, Ryang Hwa Lee
Stem Cell Research & Therapy
|
September 2, 2016
Mechanisms of mesenchymal stem/stromal cell function
Jeffrey L Spees, Ryang Hwa Lee, Carl A Gregory
Journal of Cellular Biochemistry
|
July 13, 2011
Therapeutic factors secreted by mesenchymal stromal cells and tissue repair
Ryang Hwa Lee, Joo Youn Oh, Hosoon Choi, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine
|
July 30, 2016
Stanniocalcin-1 attenuates ischemic cardiac injury and response of differentiating monocytes/macrophages to inflammatory stimuli
Arezoo Mohammadipoor, Ryang Hwa Lee, Darwin J Prockop, et al.
Cytotherapy
|
August 1, 2015
Pre-activated human mesenchymal stromal cells in combination with doxorubicin synergistically enhance tumor-suppressive activity in mice
Nara Yoon, Min Sung Park, Grantham C Peltier, et al.
The Ocular Surface
|
February 19, 2021
Mesenchymal stromal cells for corneal transplantation: Literature review and suggestions for successful clinical trials
Joo Youn Oh, Eunjae Kim, Young In Yun, et al.
Cell Stem Cell
|
November 13, 2012
Preactivation of human MSCs with TNF-α enhances tumor-suppressive activity
Ryang Hwa Lee, Nara Yoon, John C Reneau, et al.
Diabetes
|
January 26, 2013
TSG-6 produced by hMSCs delays the onset of autoimmune diabetes by suppressing Th1 development and enhancing tolerogenicity
Daniel J Kota, Lindsey L Wiggins, Nara Yoon, et al.
Page
of 5